Establishing a more modern 510(k) pathway, proposing a postmarket authority related to the disclosure of cyber-vulnerabilities, and improving the quality of real-world evidence generation for technologies that address women's health are three proposals the FDA has put forward as it looks to enhance the safety of medical devices throughout the total product lifecycle (TPLC).